drugset / Trial / NCT00377546

Comparison of Vitreous Levels of Acular LS 0.04%, Xibrom 0.09%, and Nevanac 0.1%

NCT00377546

Phase 4 Completed Innovative Medical
RandomizedParallel-groupDouble-blind

Summary

To compare the penetration of three different NSAIDs.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Bromfenac Other / unclassified
Subject Ketorolac Other / unclassified
Subject Nepafenac Other / unclassified

Indications

No indication recorded.